These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 820647)

  • 1. Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.
    Callahan LT
    Infect Immun; 1976 Jul; 14(1):55-61. PubMed ID: 820647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of Pseudomonas aeruginosa exotoxin.
    Callahan LT
    Infect Immun; 1974 Jan; 9(1):113-8. PubMed ID: 4202883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.
    Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR
    Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.
    Liu PV; Hsieh H
    J Infect Dis; 1973 Oct; 128(4):520-6. PubMed ID: 4200593
    [No Abstract]   [Full Text] [Related]  

  • 5. Temperature-dependent inactivating factor of Pseudomonas aeruginosa exotoxin A.
    Vasil ML; Liu PV; Iglewski BH
    Infect Immun; 1976 May; 13(5):1467-72. PubMed ID: 178606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.
    Pollack M; Callahan LT; Taylor NS
    Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa.
    Vasil ML; Kabat D; Iglewski BH
    Infect Immun; 1977 Apr; 16(1):353-61. PubMed ID: 406204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.
    Leppla SH
    Infect Immun; 1976 Oct; 14(4):1077-86. PubMed ID: 11187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Column chromatography and cell culture assay of Pseudomonas aeruginosa toxin Z preparations.
    Ludovici PP; Roinestad FA; Wong FS
    Appl Microbiol; 1975 Aug; 30(2):293-7. PubMed ID: 809009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of aerolysin, a lytic exotoxin from Aeromonas hydrophila.
    Bernheimer AW; Avigad LS
    Infect Immun; 1974 Jun; 9(6):1016-21. PubMed ID: 4208526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of antitoxic proteins from the serum of Agkistrodon halys Pallas.
    Niu YP; Shao JY; Jiang YL
    Toxicon; 2007 Sep; 50(3):322-9. PubMed ID: 17512568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of exotoxin of Pseudomonas aeruginosa.
    Pavlovskis OR; Callahan LT; Meyer RD
    J Infect Dis; 1974 Nov; 130 Suppl(0):S100-2. PubMed ID: 4213606
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
    Pavlovskis OR; Pollack M; Callahan LT; Iglewski BH
    Infect Immun; 1977 Dec; 18(3):596-602. PubMed ID: 412786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium oedematiens antitoxin: the correlation between anti-lethal and anti-edematizing activities.
    Izumi N; Tokumaru Y; Kondo H
    Jpn J Med Sci Biol; 1983 Apr; 36(2):75-83. PubMed ID: 6887628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of staphylococcal pyrogenic exotoxin type B.
    Schlievert PM
    Biochemistry; 1980 Dec; 19(26):6204-8. PubMed ID: 6781533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerophospholipid:cholesterol acyltransferase complexed with lipopolysaccharide (LPS) is a major lethal exotoxin and cytolysin of Aeromonas salmonicida: LPS stabilizes and enhances toxicity of the enzyme.
    Lee KK; Ellis AE
    J Bacteriol; 1990 Sep; 172(9):5382-93. PubMed ID: 2394687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exotoxin production by clinical isolates of pseudomonas aeruginosa.
    Pollack M; Taylor NS; Callahan LT
    Infect Immun; 1977 Mar; 15(3):776-80. PubMed ID: 404244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection and quantitative estimation of type A botulinum toxin by electroimmunodiffusion.
    Miller CA; Anderson AW
    Infect Immun; 1971 Aug; 4(2):126-9. PubMed ID: 5005291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIFFERENTIATION OF EXOTOXIN AND OTHER BIOLOGICALLY ACTIVE SUBSTANCES IN PSEUDOMONAS PSEUDOMALLEI FILTRATES.
    HECKLY RJ
    J Bacteriol; 1964 Dec; 88(6):1730-6. PubMed ID: 14240963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.